Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Epstein

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Blood|April 21, 2012
Unique approach for B lymphoma therapyAlan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
A new mechanism for blocking myeloid-derived suppressor cells by CpGMelissa G Lechner, Alan L Epstein
Cureus|July 24, 2019
Antibodies to Brewer's Yeast in Rheumatoid ArthritisJack R Lichtenstein, Alan L Epstein
Expert Review of Anticancer Therapy|January 13, 2021
Adopting an alternative structure for clinical trials in immunotherapyEvanthia T Roussos Torres, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapyLeslie A Khawli, Peisheng Hu, Alan L Epstein
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomasNan Zhang, Leslie A Khawli, Peisheng Hu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumorsJiali Li, Peisheng Hu, Leslie A Khawli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumorsAihong Liu, Peisheng Hu, Leslie A Khawli, et al.
Hybridoma and Hybridomics|April 26, 2003
Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumorsLeslie A Khawli, Barbara Biela, Peisheng Hu, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Blood|April 21, 2012
Unique approach for B lymphoma therapyAlan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
A new mechanism for blocking myeloid-derived suppressor cells by CpGMelissa G Lechner, Alan L Epstein
Cureus|July 24, 2019
Antibodies to Brewer's Yeast in Rheumatoid ArthritisJack R Lichtenstein, Alan L Epstein
Expert Review of Anticancer Therapy|January 13, 2021
Adopting an alternative structure for clinical trials in immunotherapyEvanthia T Roussos Torres, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapyLeslie A Khawli, Peisheng Hu, Alan L Epstein
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomasNan Zhang, Leslie A Khawli, Peisheng Hu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumorsJiali Li, Peisheng Hu, Leslie A Khawli, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumorsAihong Liu, Peisheng Hu, Leslie A Khawli, et al.
Hybridoma and Hybridomics|April 26, 2003
Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumorsLeslie A Khawli, Barbara Biela, Peisheng Hu, et al.
Pageof 10